Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study

Respir Med. 2018 Jun:139:6-12. doi: 10.1016/j.rmed.2018.04.006. Epub 2018 Apr 11.

Abstract

Background: Little is known on the prevalence and characteristics of asthma in middle-aged and older adults, since previous studies mainly focused on children and young adults. Therefore, the aim was to investigate the prevalence of physician-diagnosed asthma and its comorbidities, in a population-based cohort of adults 45 years of age and over.

Methods: We identified participants with physician-diagnosed asthma in the Rotterdam Study; a prospective population-based cohort in the Netherlands. Pulmonary function measurements and comorbidities of the asthma cases were assessed at baseline and compared to those of the general population.

Results: Out of 14,621 participants (mean age 65.5 years; 59% women), 524 subjects (31.5%males) had physician-diagnosed asthma at study entry, implicating an asthma prevalence of 3.6% [95% Confidence Interval (CI) 3.3%-3.9%] (2.8% in males and 4.2% in females). Asthmatic subjects had a significantly higher prevalence of obesity and depressive symptoms (Odds Ratio [OR]: 2,02 [95% CI 1,66-2,47] and [OR]: 2,01 [95% CI 1,52-2,66] respectively). Longer duration of asthma and current smoking were associated with lower lung function in asthmatic subjects.

Conclusion: Four percent of middle-aged and older adults have physician-diagnosed asthma. These adult asthmatics suffer more frequently from obesity and depression than subjects without obstructive lung disease.

Keywords: Asthma; Comorbidity; General population; Older adults.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Asthma / epidemiology*
  • Asthma / physiopathology
  • Depression / epidemiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Obesity / epidemiology*
  • Odds Ratio
  • Prevalence
  • Prospective Studies
  • Respiratory Function Tests
  • Smoking / adverse effects
  • Smoking / epidemiology